Key to Immunotherapy: A Computer Model Assists in Identifying Immune Cells That Fight Cancer
PD-1 inhibitors and other immune checkpoint inhibitors can be used to treat dozens of different forms of cancer.
PD-1 inhibitors and other immune checkpoint inhibitors can be used to treat dozens of different forms of cancer.
A novel method predicts how a certain DNA sequence will organize itself in the cell nucleus in a matter of minutes as opposed to days.
A recent partnership between Georgia Tech and Northwestern University has created a new high-performance organic electrochemical neuron that responds in the same frequency range as human neurons, opening up new possibilities for the area.
As people age, their risk of developing cancer rises due to a build-up of DNA damage and other factors. However, not all aberrant cells develop into cancer.
Data from this 28-country multi-institutional effort helped the Food and Drug Administration (FDA) approve this combination more quickly in December 2024, giving patients with BRAF V600E-mutant mCRC a new and effective first-line treatment choice.
The combination immunotherapy affected distant metastases in addition to the treated tumors. It increased the sensitivity of melanomas to checkpoint inhibitors and decreased the creation of new metastases, hence reducing malignant relapses.
Humans and pigs can contract the virus, which fruit bats carry. Additionally, it can spread directly from person to person by coughing droplets and contaminated food.
The huntingtin gene’s three DNA blocks (C, A, and G) repeatedly expanding are the source of the illness.
HIV-1, like other viruses, lacks the equipment to generate its own proteins and must rely on the host cell to translate its genetic instructions.
Researchers from the Technical University of Denmark and the UW Medicine Institute for Protein Design are spearheading a computational biology initiative to find more effective antivenom treatments.